Blood safety study: can antibodies to treated red cells trigger reactions?
NCT ID NCT07152379
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This study looks at whether people who have antibodies to specially treated red blood cells (INTERCEPT RBCs) might have a reaction when they receive a transfusion of these cells. Ten participants will be enrolled, some with and some without these antibodies. The goal is to understand if these antibodies cause faster breakdown of the transfused cells or other side effects, which could help make blood transfusions safer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION REACTION, HEMOLYTIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.